BioSpace News Archive

Mirati Therapeutics, Inc., a targeted oncology company, will participate in two upcoming healthcare conferences.

ImmunoGen, Inc. announced that the following presentations by Company management at upcoming investor conferences will be webcast.

Align Technology, Inc., a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, reported financial results for the fourth quarter and year ended December 31, 2022.

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, announced that it has granted an inducement award to one new employee, Jennifer Neumann, who joined Oncternal as Director, Clinical Data Management.

ProSomnus, Inc., a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea, announced certain unaudited results for the quarter and full year ended December 31, 2022.

St. Luke’s Health and its academic affiliate Baylor College of Medicine are back in-network with Cigna, adding the insurer to a large group of in-network carriers.

Today, the U.S. Food and Drug Administration approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia (decreased number of red blood cells) caused by chronic kidney disease for adults who have been receiving dialysis for at least four months.

Adicet Bio, Inc. today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the 2023 Guggenheim Oncology Conference being held from February 8-9, 2023.

ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will participate in two investor conferences in February.

TRISO-X LLC (“TRISO-X”), a wholly owned subsidiary of X-Energy Reactor Company, LLC (“X-energy” or the “Company”), a leading developer of advanced small modular nuclear reactors and fuel technology for clean energy generation, marked another step forward in the licensing of its fuel fabrication facility in Oak Ridge, Tennessee, as the Nuclear Regulatory Commission (“NRC” or “Commission”) hosted its first public meeting for the proposed facility.